Folgen
Prof. Dr. Hans-Martin Fritsche
Prof. Dr. Hans-Martin Fritsche
Ambulante Urologie im DEZ
Bestätigte E-Mail-Adresse bei ukr.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
S Denzinger, HM Fritsche, W Otto, A Blana, WF Wieland, M Burger
European urology 53 (1), 146-152, 2008
2192008
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort
HM Fritsche, M Burger, RS Svatek, C Jeldres, PI Karakiewicz, G Novara, ...
European urology 57 (2), 300-309, 2010
2182010
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma
E Xylinas, M Rink, EK Cha, T Clozel, RK Lee, H Fajkovic, E Comploj, ...
European urology 65 (1), 210-217, 2014
2112014
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients
G Novara, RS Svatek, PI Karakiewicz, E Skinner, V Ficarra, Y Fradet, ...
The Journal of urology 183 (6), 2165-2170, 2010
2052010
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
RS Svatek, SF Shariat, G Novara, EC Skinner, Y Fradet, PJ Bastian, ...
BJU international 107 (6), 898-904, 2011
1922011
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma
EK Cha, SF Shariat, M Kormaksson, G Novara, TF Chromecki, DS Scherr, ...
European urology 61 (4), 818-825, 2012
1892012
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma
EK Cha, SF Shariat, M Kormaksson, G Novara, TF Chromecki, DS Scherr, ...
European urology 61 (4), 818-825, 2012
1892012
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
F Soria, SF Shariat, SP Lerner, HM Fritsche, M Rink, W Kassouf, ...
World journal of urology 35 (3), 379-387, 2017
1862017
Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort
A Aziz, M May, M Burger, RJ Palisaar, QD Trinh, HM Fritsche, M Rink, ...
European urology 66 (1), 156-163, 2014
1732014
Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study
G Novara, K Matsumoto, W Kassouf, TJ Walton, HM Fritsche, PJ Bastian, ...
European urology 57 (6), 1064-1071, 2010
1712010
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma
SF Shariat, RL Favaretto, A Gupta, HM Fritsche, K Matsumoto, W Kassouf, ...
World journal of urology 29 (4), 481-486, 2011
1702011
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
SF Shariat, RS Svatek, D Tilki, E Skinner, PI Karakiewicz, U Capitanio, ...
BJU international 105 (10), 1402-1412, 2010
1552010
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision …
M Rouprêt, V Hupertan, T Seisen, P Colin, E Xylinas, DR Yates, ...
The Journal of urology 189 (5), 1662-1669, 2013
1512013
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool
E Xylinas, L Kluth, N Passoni, QD Trinh, M Rieken, RK Lee, H Fajkovic, ...
European urology 65 (3), 650-658, 2014
1382014
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool
E Xylinas, L Kluth, N Passoni, QD Trinh, M Rieken, RK Lee, H Fajkovic, ...
European urology 65 (3), 650-658, 2014
1382014
The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary BladderOff-Protocol Adjuvant Chemotherapy for Bladder Cancer
RS Svatek, SF Shariat, RE Lasky, EC Skinner, G Novara, SP Lerner, ...
Clinical Cancer Research 16 (17), 4461-4467, 2010
1382010
The plasmacytoid carcinoma of the bladder—rare variant of aggressive urothelial carcinoma
B Keck, R Stoehr, S Wach, A Rogler, F Hofstaedter, J Lehmann, ...
International journal of cancer 129 (2), 346-354, 2011
1192011
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series …
FA Yafi, G Novara, SF Shariat, A Gupta, K Matsumoto, TJ Walton, ...
BJU international 110 (2b), E7-E13, 2012
1152012
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node–negative urothelial carcinoma of …
M May, E Herrmann, C Bolenz, S Brookman-May, A Tiemann, R Moritz, ...
Annals of surgical oncology 18 (7), 2018-2025, 2011
1122011
Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer
R Ganzer, HM Fritsche, A Brandtner, J Bründl, D Koch, WF Wieland, ...
BJU Int 112 (3), 322-9, 2013
1102013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20